A significant breakthrough in cancer study is emerging with the use of mini-antibodies to re-engage damaged p53. This crucial cancer inhibitor protein is frequently inactivated in many types of malignancies, causing https://socialrator.com/story13360420/vhh-fragments-revive-p53-a-new-pathway-for-cancer-management